CeriBell Inc. CBLL recently announced that the FDA has given 510(k) clearance for its latest delirium monitoring solution, making it the one and only FDA-cleared solution for continuous tracking of ...
Please provide your email address to receive an email when new articles are posted on . Use of an AI model resulted in a nearly fourfold increase in delirium cases detected among hospitalized older ...
SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results